We are live on ! Find out more
KOC

Koss-Olinger Consulting Portfolio holdings

AUM $1.19B
1-Year Est. Return 15.91%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+15.91%
3 Year Est. Return
+50.95%
5 Year Est. Return
+57.89%
10 Year Est. Return
AUM
$1.14B
AUM Growth
-$11.1M
Cap. Flow
-$9.14M
Cap. Flow %
-0.8%
Top 10 Hldgs %
54.06%
Holding
302
New
26
Increased
76
Reduced
67
Closed
117

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 5.09%
2 Technology 3.16%
3 Financials 2.26%
4 Healthcare 1.96%
5 Communication Services 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PII icon
76
Polaris
PII
$3.83B
$1.56M 0.14%
27,046
+3,236
+14% +$225K
QVMT
77
Invesco S&P 500 Concentrated QVM ETF
QVMT
$128M
$1.53M 0.13%
31,072
-804
-3% -$41.1K
PLTR icon
78
Palantir
PLTR
$295B
$1.5M 0.13%
19,864
+630
+3% +$36.7K
XSOE icon
79
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$1.93B
$1.5M 0.13%
49,203
+393
+0.8% +$12.6K
IXN icon
80
iShares Global Tech ETF
IXN
$7.87B
$1.45M 0.13%
17,158
+246
+1% +$20.7K
MDT icon
81
Medtronic
MDT
$112B
$1.42M 0.12%
17,759
-2,833
-14% -$245K
IFF icon
82
International Flavors & Fragrances
IFF
$20.3B
$1.36M 0.12%
16,110
+1,593
+11% +$150K
MBUU icon
83
Malibu Boats
MBUU
$548M
$1.36M 0.12%
36,196
-10,866
-23% -$450K
CRSP icon
84
CRISPR Therapeutics
CRSP
$4.69B
$1.34M 0.12%
34,168
+18,298
+115% +$864K
SCHF icon
85
Schwab International Equity ETF
SCHF
$64.9B
$1.33M 0.12%
71,745
+609
+0.9% +$11.9K
CVS icon
86
CVS Health
CVS
$135B
$1.29M 0.11%
28,719
-6,165
-18% -$346K
VTIP icon
87
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$1.26M 0.11%
25,975
-767
-3% -$37.5K
XYZ
88
Block Inc
XYZ
$48.9B
$1.25M 0.11%
+14,668
New +$1.2M
SSNC icon
89
SS&C Technologies
SSNC
$18.9B
$1.23M 0.11%
+16,287
New +$1.22M
AMCX icon
90
AMC Global Media
AMCX
$450M
$1.19M 0.1%
119,867
-35,654
-23% -$315K
MAC icon
91
Macerich
MAC
$7.4B
$1.16M 0.1%
58,134
-16,709
-22% -$326K
ERIC icon
92
Ericsson
ERIC
$32.1B
$1.14M 0.1%
141,819
-41,963
-23% -$341K
LRCX icon
93
Lam Research
LRCX
$316B
$1.14M 0.1%
+15,770
New +$1.2M
BABA icon
94
Alibaba
BABA
$276B
$1.08M 0.09%
+12,752
New +$1.2M
BBW icon
95
Build-A-Bear
BBW
$445M
$984K 0.09%
21,370
+1,184
+6% +$46K
TSN icon
96
Tyson Foods
TSN
$21.5B
$941K 0.08%
16,386
-3,794
-19% -$229K
BSCQ icon
97
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.66B
$933K 0.08%
47,997
+7,817
+19% +$152K
BSCP
98
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$932K 0.08%
45,136
+2,555
+6% +$52.8K
ISMD icon
99
Inspire Small/Mid Cap Impact ETF
ISMD
$332M
$926K 0.08%
24,686
-1,569
-6% -$60.5K
KRC icon
100
Kilroy Realty
KRC
$4.59B
$888K 0.08%
21,961
-6,501
-23% -$262K

Similar funds

Koss-Olinger Consulting's Q4 2024 Portfolio in Review

As of Q4 2024, Koss-Olinger Consulting held 302 positions worth $1.14B, down 0.96% from $1.15B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Koss-Olinger Consulting's Q4 2024 filing shows 26 new, 76 increased, 67 reduced and 117 closed positions. Its largest new stake was Incyte: 24,283 shares worth $1.68M. The largest sale was Tesla, an estimated $21.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 5.1% of assets, down from 5.9% a quarter earlier, followed by Technology and Financials.

  • Koss-Olinger Consulting's largest Q4 2024 buy was Incyte: 24,283 shares worth $1.68M.
  • Koss-Olinger Consulting added most to PIMCO Active Bond Exchange-Traded Fund in Q4 2024, an estimated $37.7M increase.
  • Koss-Olinger Consulting's biggest Q4 2024 reduction was Tesla, cutting an estimated $21.8M.
  • Koss-Olinger Consulting fully exited Vanguard S&P 500 ETF in Q4 2024, selling an estimated $3.7M.
  • Koss-Olinger Consulting's ten largest holdings make up 54% of its $1.14B portfolio in Q4 2024.
  • Koss-Olinger Consulting opened 26 new positions and closed 117 in Q4 2024.
  • Koss-Olinger Consulting's portfolio value fell 0.96% quarter-over-quarter to $1.14B.

Based on Koss-Olinger Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.